使用复合激活因子VII,以阻止儿童脏活检后出血
Elena Park1, Stephanie P Kerkvliet2, Andrew D Hughes3
1Geisinger College of Health Sciences, Scranton, PA, USA.
Pediatric nephrology (Berlin, Germany)
|December 2, 2025
概括
在标准治疗失败时,复合激活因子VII (rFVIIa) 在儿科患者的脏活检后有效地停止了严重出血. 这凸显了rFVIIa作为管理活检后出血的关键选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 血液学 血液学 血液学
- 儿科医学 儿科医学
背景情况:
- 脏活检对于诊断脏疾病至关重要.
- 严重出血是活检的一个罕见但严重的并发症.
- 对于活检后出血存在有限的有效治疗方法.
研究的目的:
- 报告小儿病人的脏活检后严重出血病例.
- 评估复合激活因子VII (rFVIIa) 治疗这种并发症的疗效.
主要方法:
- 一名患有ANCA血管炎的10岁女性接受了脏活检.
- 患者在活检后出现了严重的,不受控制的出血和血液瘤.
- 用德斯莫普林,压力和血小板输血治疗无效.
- 进行了重组激活因子VII (rFVIIa) 的治疗.
主要成果:
- 再组合激活因子VII (rFVIIa) 的使用导致出血立即停止.
- 患者的血液瘤稳定,没有进一步的并发症.
结论:
- 复合激活因子VII (rFVIIa) 是一种可行且有效的治疗方法,用于严重的脏活检后出血.
- 这个案例支持在传统的静血策略失败时使用rFVIIa.
相关概念视频
Venous Thrombosis III: Interprofessional Care
254
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
254
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Imaging Studies VII: Vascular Imaging
282
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
282
Hemodialysis I: Introduction
1.1K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Kidney Transplant II: Surgical Procedure
270
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
270


